Interleukin-2 induces an early step in the activation of interferon-gamma gene expression

Immunol Lett. 1995 Jan;44(2-3):213-6. doi: 10.1016/0165-2478(94)00217-f.

Abstract

Establishment of protective immunity depends critically on IFN-gamma. We show that in human peripheral blood mononuclear cells, low doses of IL-2 greatly potentiate the response of the IFN-gamma gene to mitogen, by over 100-fold. By itself, IL-2 is unable to induce IFN-gamma mRNA to a significant extent. Yet, exposure to IL-2 leads to cellular commitment within a few hours, expressed by greatly enhanced accumulation of IFN-gamma mRNA upon subsequent exposure to phytohemagglutinin. Changes induced by IL-2 do not relieve the requirement for de novo protein synthesis during the early phases of induction of IFN-gamma gene expression. IL-2 may induce a component essential for induction of IFN-gamma mRNA that is utilized during subsequent exposure to a mitogenic signal. Our results demonstrate synergy between IL-2 and mitogen in IFN-gamma gene induction.

MeSH terms

  • Cells, Cultured
  • Cycloheximide / pharmacology
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation*
  • Humans
  • Interferon-gamma / biosynthesis*
  • Interferon-gamma / genetics
  • Interleukin-2 / pharmacology*
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / metabolism
  • Lymphocyte Activation
  • Phytohemagglutinins / pharmacology
  • Protein Biosynthesis
  • RNA, Messenger / analysis
  • Time Factors
  • Transcriptional Activation

Substances

  • Interleukin-2
  • Phytohemagglutinins
  • RNA, Messenger
  • Interferon-gamma
  • Cycloheximide